0001171843-22-004515.txt : 20220623 0001171843-22-004515.hdr.sgml : 20220623 20220623163407 ACCESSION NUMBER: 0001171843-22-004515 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220622 FILED AS OF DATE: 20220623 DATE AS OF CHANGE: 20220623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ford Brian D. CENTRAL INDEX KEY: 0001825758 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35776 FILM NUMBER: 221035916 MAIL ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acasti Pharma Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 BUSINESS PHONE: 450-686-4555 MAIL ADDRESS: STREET 1: 3009, BOUL. DE LA CONCORDE EAST STREET 2: SUITE 102 CITY: LAVAL STATE: A8 ZIP: H7E 2B5 4 1 ownership.xml X0306 4 2022-06-22 0 0001444192 Acasti Pharma Inc. ACST 0001825758 Ford Brian D. C/O ACASTI PHARMA INC. 3009 BOUL. DE LA CONCORDE, SUITE 102 LAVAL A6 H7E 2B5 ONTARIO, CANADA 0 1 0 0 CHIEF FINANCIAL OFFICER Stock Options (Right to Buy) 0.89 2022-06-22 4 A 0 165000 0 A 2032-06-22 Class A Common Shares 165000 165000 D Based on conversion of exercise price of C$1.15 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7727 on the date of grant. Stock options granted on 06/22/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months. /s/ Jason Comerford, attorney-in fact for Mr. Ford 2022-06-23